Literature DB >> 17620373

Haemophilus ducreyi is resistant to human antimicrobial peptides.

Kristy L B Mount1, Carisa A Townsend, Margaret E Bauer.   

Abstract

We examined the susceptibility of Haemophilus ducreyi to antimicrobial peptides likely to be encountered in vivo during human infection. H. ducreyi was significantly more resistant than Escherichia coli to the bactericidal effects of all peptides tested. Class I and II H. ducreyi strains exhibited similar levels of resistance to antimicrobial peptides.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17620373      PMCID： PMC2043175          DOI： 10.1128/AAC.00473-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  20 in total

1.  Haemophilus ducreyi associates with phagocytes, collagen, and fibrin and remains extracellular throughout infection of human volunteers.

Authors:  M E Bauer; M P Goheen; C A Townsend; S M Spinola
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

2.  Transcription of candidate virulence genes of Haemophilus ducreyi during infection of human volunteers.

Authors:  R E Throm; S M Spinola
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

3.  Defensin-rich granules of human neutrophils: characterization of secretory properties.

Authors:  Mikkel Faurschou; Ole E Sørensen; Anders H Johnsen; Jon Askaa; Niels Borregaard
Journal:  Biochim Biophys Acta       Date:  2002-08-19

4.  Gene expression, immunolocalization, and secretion of human defensin-5 in human female reproductive tract.

Authors:  A J Quayle; E M Porter; A A Nussbaum; Y M Wang; C Brabec; K P Yip; S C Mok
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

5.  Expression of natural peptide antibiotics in human skin.

Authors:  C Fulton; G M Anderson; M Zasloff; R Bull; A G Quinn
Journal:  Lancet       Date:  1997-12-13       Impact factor: 79.321

6.  The non-typeable Haemophilus influenzae Sap transporter provides a mechanism of antimicrobial peptide resistance and SapD-dependent potassium acquisition.

Authors:  Kevin M Mason; Molly E Bruggeman; Robert S Munson; Lauren O Bakaletz
Journal:  Mol Microbiol       Date:  2006-10-25       Impact factor: 3.501

7.  Localization of Haemophilus ducreyi at the pustular stage of disease in the human model of infection.

Authors:  M E Bauer; S M Spinola
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

8.  Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity.

Authors:  R I Lehrer; A Barton; K A Daher; S S Harwig; T Ganz; M E Selsted
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

9.  Susceptibility of nontypeable Haemophilus influenzae to human beta-defensins is influenced by lipooligosaccharide acylation.

Authors:  Timothy D Starner; W Edward Swords; Michael A Apicella; Paul B McCray
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

10.  Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense.

Authors:  De Yang; Arya Biragyn; David M Hoover; Jacek Lubkowski; Joost J Oppenheim
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527
View more
  8 in total

Review 1.  On the physiology and pathophysiology of antimicrobial peptides.

Authors:  Roland Pálffy; Roman Gardlík; Michal Behuliak; Ludevit Kadasi; Jan Turna; Peter Celec
Journal:  Mol Med       Date:  2008-11-10       Impact factor: 6.354

2.  Deletion of mtrC in Haemophilus ducreyi increases sensitivity to human antimicrobial peptides and activates the CpxRA regulon.

Authors:  Sherri D Rinker; Michael P Trombley; Xiaoping Gu; Kate R Fortney; Margaret E Bauer
Journal:  Infect Immun       Date:  2011-03-28       Impact factor: 3.441

3.  Haemophilus ducreyi SapA contributes to cathelicidin resistance and virulence in humans.

Authors:  Kristy L B Mount; Carisa A Townsend; Sherri D Rinker; Xiaoping Gu; Kate R Fortney; Beth W Zwickl; Diane M Janowicz; Stanley M Spinola; Barry P Katz; Margaret E Bauer
Journal:  Infect Immun       Date:  2010-01-19       Impact factor: 3.441

Review 4.  Host-pathogen interplay of Haemophilus ducreyi.

Authors:  Diane M Janowicz; Wei Li; Margaret E Bauer
Journal:  Curr Opin Infect Dis       Date:  2010-02       Impact factor: 4.915

5.  Phosphoethanolamine Transferase LptA in Haemophilus ducreyi Modifies Lipid A and Contributes to Human Defensin Resistance In Vitro.

Authors:  Michael P Trombley; Deborah M B Post; Sherri D Rinker; Lorri M Reinders; Kate R Fortney; Beth W Zwickl; Diane M Janowicz; Fitsum M Baye; Barry P Katz; Stanley M Spinola; Margaret E Bauer
Journal:  PLoS One       Date:  2015-04-22       Impact factor: 3.240

6.  The Human Skin Microbiome Associates with the Outcome of and Is Influenced by Bacterial Infection.

Authors:  Julia J van Rensburg; Huaiying Lin; Xiang Gao; Evelyn Toh; Kate R Fortney; Sheila Ellinger; Beth Zwickl; Diane M Janowicz; Barry P Katz; David E Nelson; Qunfeng Dong; Stanley M Spinola
Journal:  mBio       Date:  2015-09-15       Impact factor: 7.867

7.  SapF-mediated heme-iron utilization enhances persistence and coordinates biofilm architecture of Haemophilus.

Authors:  Andrew R Vogel; Blake R Szelestey; Forrest K Raffel; Samantha W Sharpe; Rachel L Gearinger; Sheryl S Justice; Kevin M Mason
Journal:  Front Cell Infect Microbiol       Date:  2012-04-03       Impact factor: 5.293

8.  Both group 4 capsule and lipopolysaccharide O-antigen contribute to enteropathogenic Escherichia coli resistance to human α-defensin 5.

Authors:  Jenny-Lee Thomassin; Mark J Lee; John R Brannon; Donald C Sheppard; Samantha Gruenheid; Hervé Le Moual
Journal:  PLoS One       Date:  2013-12-04       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.